Drug recall
Premarin (conjugated estrogens tablets, USP), 0.625 mg, 100 and 1000 count bottles, Rx only, Manufactured by…
FDA recall event 29524 · Class III · Rx PAK
Key facts
| Event ID | 29524 |
|---|---|
| Recall numbers | D-231-4 |
| Recalling firm | Rx PAK |
| Product type | Drugs |
| Products | Premarin (conjugated estrogens tablets, USP), 0.625 mg, 100 and 1000 count bottles, Rx only, Manufactured by Ayerst Laboratories Inc., A Wyeth-Ayerst Company, Philadelphia, PA 19101 Repackaged by… |
| Classification | Class III |
| Status | Completed |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Dissolution Failure: Product failed to meet dissolution specifications |
| Initiation date | May 3, 2004 |
| City | Memphis |
| Country | United States |
| FEI number | 3002574153 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports